HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of advanced ampullary carcinoma successfully resected after primary chemotherapy with s-1 and gemcitabine].

Abstract
The patient was a 53-year-old male who was admitted on an emergency basis with obstructive jaundice. He was diagnosed as having advanced ampullary carcinoma(T4 N0 H1, Stage IV b). To reduce the degree of obstructive jaundice, a self-expandable metallic stent was placed in the area of the biliary obstruction. Immediately after relief from obstructive jaundice, combination chemotherapy of S-1 and gemcitabine was given. Subsequently, CA19-9, the tumormarker level was reduced, the metastatic liver tumor disappeared, and the size of the primary lesion was remarkably reduced. Therefore, a curative surgical resection was done. This is a very instructive case for developing effective chemotherapy options to treat biliary tract cancers involving ampullary carcinoma.
AuthorsTomoyoshi Ohno, Hiroki Koguchi, Aki Miura, Yoshito Tanaka, Masayuki Endo, Seijiro Matsunaga, Izumi Hasegawa, Atsunaga Kato, Yasushi Tokuda, Kenji Sakakibara
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 36 Issue 6 Pg. 999-1002 (Jun 2009) ISSN: 0385-0684 [Print] Japan
PMID19542724 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • Deoxycytidine
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Gemcitabine
Topics
  • Ampulla of Vater
  • Antimetabolites, Antineoplastic (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Deoxycytidine (administration & dosage, analogs & derivatives)
  • Drug Combinations
  • Duodenal Neoplasms (complications, drug therapy, surgery)
  • Humans
  • Jaundice, Obstructive (etiology)
  • Male
  • Middle Aged
  • Oxonic Acid (administration & dosage)
  • Tegafur (administration & dosage)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: